On December 19, 2023 Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, reported that that its Chief Executive Officer, Michael Engsig will present at the 42nd Annual J.P. Morgan Healthcare Conference and is available for 1:1 investor meetings (Press release, Nykode Therapeutics, DEC 19, 2023, View Source [SID1234638685]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Wednesday, January 10, 2024
Time: 3:45 pm PST
Webcast: View Source;kiosk=true

The presentation, as well as a live audio and archived webcast of the presentation can be accessed in the Investors section of the Company’s website: View Source